Skip to main content

Newsroom press releases

28/12/25 - 18:48

Diasorin receives FDA 510(k) clearance and CLIA-waiver for its first assay, the 4-Plex Respiratory Panel, on the LIAISON NES Molecular Diagnostics platform (140.92 KB)
Products Molecular
Download

22/12/25 - 17:25

2026 Annual Corporate Events Calendar (117.34 KB)
Other
Download

22/12/25 - 14:36

The Board of Directors approved to submit to the Shareholders' Meeting the authorization for the purchase and cancellation of treasury shares for the purpose of shareholder remuneration. Ordinary and extraordinary shareholders' meeting convened. (125.84 KB)
Other
Download

24/11/25 - 11:10

Diasorin submits the LIAISON PLEX Gastrointestinal Flex Assay to the U.S. FDA for 510(k) Clearance (128.44 KB)
Products Molecular
Download

18/11/25 - 6:30

Diasorin, in partnership with QIAGEN, unveils the next generation of the LIAISON QuantiFERON-TB Gold Plus II assay to deliver significant testing productivity and faster results in all Countries accepting the CE mark (147.94 KB)
Products Immunodiagnostic
Download

05/11/25 - 17:46

Diasorin’s Board of Directors approves results for the first 9 months of 2025. FY 2025 Guidance revised (255.77 KB)
Financial Data
Download

31/10/25 - 10:12

Diasorin receives 510(k) clearance for Simplexa COVID-19, Flu A/B & RSV Direct kit on the LIAISON MDX from the U.S. Food and Drug Administration (132.55 KB)
Products Molecular
Download

22/10/25 - 7:41

Diasorin signs a supplier agreement with Quest Diagnostics for the innovative molecular multiplexing platform, LIAISON PLEX (125.42 KB)
Molecular
Download

19/09/25 - 9:34

Diasorin launches LIAISON® TSH-R Ab, an immunodiagnostic assay to improve Graves’ Disease diagnosis, in all countries accepting CE mark (130.17 KB)
Products Immunodiagnostic
Download

08/09/25 - 11:16

New evidence on MeMed BV's role in supporting emergency medicine clinical decisions unveiled at ACEP 2025 (136.64 KB)
Products Immunodiagnostic
Download

31/07/25 - 16:22

Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed (238.17 KB)
Financial Data
Download

02/07/25 - 8:10

Diasorin submits the LIAISON NES® Point-of-Care molecular diagnostics system and 4-plex Respiratory Panel to the FDA for 510(k) Clearance and CLIA Waiver (133.82 KB)
Products Molecular
Download

07/06/25 - 12:25

Diasorin announces 510(k) clearance for LIAISON PLEX® Gram-Positive Blood Culture Assay, to complete the Blood Culture portfolio on LIAISON PLEX® (143.05 KB)
Products Molecular
Download

06/05/25 - 17:41

Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)
Financial Data
Download

18/04/25 - 18:11

Diasorin receives 510(k) clearance for its second multiplex molecular panel for diagnosing bloodstream infections on LIAISON PLEX® (161.29 KB)
Products
Download

18/03/25 - 11:54

Diasorin launches the Simplexa™ C. auris direct assay on the LIAISON® MDX instrument in all countries accepting the CE Mark (126.65 KB)
Products Molecular
Download

14/03/25 - 16:29

The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)
Financial Data
Download

23/12/11 - 1:00

Financial instruments to employees (57.22 KB)
Financial Data
Download

19/12/11 - 1:00

Clostridium Difficile toxins A and B in stool on LIAISON (available outside the US and Canada only) (192.66 KB)
Products Immunodiagnostic
Download

19/11/11 - 1:00

Buy-back plan (35.47 KB)
Financial Data
Download

18/11/11 - 1:00

Financial instruments to employees (56.82 KB)
Financial Data
Download

11/11/11 - 1:00

The BoD approves Q3'11 results (334.35 KB)
Financial Data
Download

28/10/11 - 2:00

Buy-back plan (103.99 KB)
Financial Data
Download

25/10/11 - 2:00

Buy-back plan (104.72 KB)
Financial Data
Download

18/10/11 - 2:00

Buy-back plan (136.18 KB)
Financial Data
Download

17/10/11 - 2:00

2011-2015 Business Plan: a new business wave (195.1 KB)
Financial Data
Download

10/10/11 - 2:00

New Chief Financial Officer (196.26 KB)
Other
Download

06/10/11 - 2:00

Cardinal Health: agreement extended to 2014 (192.57 KB)
Acquisition / Partnership
Download

04/10/11 - 2:00

Buy-back plan (204.92 KB)
Financial Data
Download

01/09/11 - 2:00

Resignation of Chief Financial Officer (177.77 KB)
Other
Download

31/08/11 - 2:00

2011 Financial calendar update (176.4 KB)
Financial Data
Download

03/08/11 - 2:00

The BoD approves H1'11 results (324.48 KB)
Financial Data
Download

11/07/11 - 2:00

Voluntarily removal from the STAR segment (194.93 KB)
Financial Data
Download

13/05/11 - 2:00

The BoD approves Q1'11 results (307.28 KB)
Financial Data
Download

11/05/11 - 2:00

DiaSorin and Labcorp extend strategic business relationship (100.01 KB)
Acquisition / Partnership
Download

06/05/11 - 2:00

Agreement with Precision System Science Co., LTD (171.54 KB)
Acquisition / Partnership
Download

28/04/11 - 2:00

The Ordinary Shareholders' meeting approves the 2010 statutory financial statements and the dividend distribution (175.61 KB)
Financial Data
Download

16/03/11 - 1:00

The BoD approves FY'10 results (368.28 KB)
Financial Data
Download

16/03/11 - 1:00

Dividend information amendment (159.83 KB)
Financial Data
Download

28/02/11 - 1:00

2011 Financial calendar update (179.92 KB)
Financial Data
Download

19/02/11 - 1:00

Notice of change in share capital (5.28 KB)
Financial Data
Download

18/02/11 - 1:00

Buy-back plan (134.06 KB)
Financial Data
Download

17/02/11 - 1:00

Financial instruments to employees (56.37 KB)
Financial Data
Download

16/02/11 - 1:00

Buy-back plan (105.2 KB)
Financial Data
Download

15/02/11 - 1:00

Buy-back plan (91.38 KB)
Financial Data
Download

14/02/11 - 1:00

The BoD approves Q4'10 results (161 KB)
Financial Data
Download

31/01/11 - 1:00

Buy-back plan (105.05 KB)
Financial Data
Download

29/01/11 - 1:00

Buy-back plan (105.2 KB)
Financial Data
Download

28/01/11 - 1:00

Buy-back plan (105.04 KB)
Financial Data
Download

27/01/11 - 1:00

Buy-back plan (105.04 KB)
Financial Data
Download

26/01/11 - 1:00

FDA approves the LIAISON XL (194.2 KB)
Products Immunodiagnostic
Download

25/01/11 - 1:00

Buy-back plan (105.22 KB)
Financial Data
Download

24/01/11 - 1:00

Buy-back plan (104.72 KB)
Financial Data
Download

21/01/11 - 1:00

Buy-back plan (105.05 KB)
Financial Data
Download

20/01/11 - 1:00

Buy-back plan (91.39 KB)
Financial Data
Download

19/01/11 - 1:00

Buy-back plan (105.31 KB)
Financial Data
Download

18/01/11 - 1:00

Buy-back plan (35.47 KB)
Financial Data
Download

17/01/11 - 1:00

Buy-back plan (134.01 KB)
Financial Data
Download

17/01/11 - 1:00

The Sonic Healthcare Group chooses DiaSorin (181.71 KB)
Acquisition / Partnership
Download

16/01/11 - 1:00

2011 Financial calendar (179.49 KB)
Financial Data
Download
Price Sensitive

eMarket SDIR System and eMarket STORAGE
For the dissemination and the storage of Regulated Information, DiaSorin S.p.A. uses the eMarket SDIR circuit and the eMarket STORAGE mechanism (available at the address www.emarketstorage.it), managed by Teleborsa S.r.l., with registered office in Piazza di Priscilla, 4, Rome, Italy.